![](https://ml.globenewswire.com/media/7d55186f-ce46-45ab-b1c2-fd0c843890aa/small/logo-1200x628-jpg.jpg)
CytoSorbents Announces Compliance with Nasdaq Minimum Bid Price Requirement
PRINCETON, N.J., Aug. 01, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of deadly conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption …